Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China
· Delayed Price · Currency is CNY 12.40
-0.32 (-2.52%)
Feb 28, 2025, 2:45 PM CST
SHA:603707 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 20,066 | 24,169 | 29,075 | 52,058 | 32,706 | 29,701 | Upgrade
|
| Market Cap Growth | 14.97% | -16.87% | -44.15% | 59.17% | 10.12% | 187.42% | Upgrade
|
| Enterprise Value | 20,421 | 25,024 | 30,396 | 54,143 | 34,595 | 30,425 | Upgrade
|
| Last Close Price | 12.42 | 14.87 | 17.73 | 31.59 | 20.25 | 18.30 | Upgrade
|
| PE Ratio | - | - | 26.65 | 49.14 | 40.57 | 49.10 | Upgrade
|
| Forward PE | 22.65 | 19.44 | 19.56 | 38.80 | 33.70 | 43.66 | Upgrade
|
| PS Ratio | 5.11 | 6.15 | 7.83 | 14.12 | 11.22 | 12.03 | Upgrade
|
| PB Ratio | 3.20 | 4.17 | 4.71 | 9.64 | 8.73 | 9.89 | Upgrade
|
| P/TBV Ratio | 3.94 | 4.39 | 4.91 | 10.13 | 9.35 | 10.75 | Upgrade
|
| P/FCF Ratio | 23.52 | 20.14 | 231.92 | 214.34 | - | - | Upgrade
|
| P/OCF Ratio | 15.64 | 14.93 | 48.83 | 76.15 | - | - | Upgrade
|
| EV/Sales Ratio | 5.27 | 6.37 | 8.19 | 14.69 | 11.87 | 12.32 | Upgrade
|
| EV/EBITDA Ratio | - | - | 26.18 | 40.86 | 34.17 | 42.41 | Upgrade
|
| EV/EBIT Ratio | - | - | 29.76 | 43.96 | 37.28 | 45.25 | Upgrade
|
| EV/FCF Ratio | 23.94 | 20.85 | 242.46 | 222.93 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.37 | 0.45 | 0.48 | 0.38 | 0.87 | 0.46 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 2.56 | 1.55 | 3.22 | 1.92 | Upgrade
|
| Debt / FCF Ratio | 2.71 | 2.16 | 23.70 | 8.45 | - | - | Upgrade
|
| Asset Turnover | 0.38 | 0.40 | 0.41 | 0.46 | 0.46 | 0.58 | Upgrade
|
| Inventory Turnover | 0.76 | 0.67 | 0.34 | 0.34 | 0.32 | 0.46 | Upgrade
|
| Quick Ratio | 1.43 | 0.86 | 0.96 | 0.88 | 0.80 | 0.44 | Upgrade
|
| Current Ratio | 3.13 | 2.35 | 3.07 | 3.06 | 2.41 | 2.11 | Upgrade
|
| Return on Equity (ROE) | -6.46% | -3.17% | 18.78% | 23.26% | 23.61% | 22.35% | Upgrade
|
| Return on Assets (ROA) | -3.05% | -2.13% | 7.01% | 9.66% | 9.06% | 9.91% | Upgrade
|
| Return on Capital (ROIC) | -3.36% | -2.37% | 7.70% | 10.65% | 10.19% | 11.79% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 13.98% | 20.70% | 18.88% | 22.08% | Upgrade
|
| Earnings Yield | -2.11% | -0.78% | 3.75% | 2.03% | 2.46% | 2.04% | Upgrade
|
| FCF Yield | 4.25% | 4.97% | 0.43% | 0.47% | -2.63% | -3.22% | Upgrade
|
| Dividend Yield | 0.81% | 0.67% | 0.65% | 0.37% | 0.44% | 0.75% | Upgrade
|
| Payout Ratio | 0.00% | - | 20.78% | 18.10% | 32.40% | 16.64% | Upgrade
|
| Buyback Yield / Dilution | 1.71% | 3.03% | -2.98% | 0.43% | -0.94% | 0.52% | Upgrade
|
| Total Shareholder Return | 2.51% | 3.71% | -2.33% | 0.79% | -0.50% | 1.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.